MASI MASIMO CORP

Nasdaq masimo.com


$ 148.97 $ -0.30 (-0.2 %)    

Friday, 24-Oct-2025 12:25:30 EDT
QQQ $ 617.78 $ 1.78 (0.29 %)
DIA $ 472.85 $ 2.98 (0.63 %)
SPY $ 678.10 $ 1.62 (0.24 %)
TLT $ 91.50 $ -0.06 (-0.07 %)
GLD $ 380.49 $ 1.87 (0.49 %)
$ 148.73
$ 149.63
$ 148.82 x 89
$ 149.02 x 4
$ 148.41 - $ 149.63
$ 133.70 - $ 194.88
438,694
na
8.08B
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-28-2025 10-Q
2 05-06-2025 03-29-2025 10-Q
3 02-25-2025 12-28-2024 10-K
4 11-06-2024 09-28-2024 10-Q
5 08-06-2024 06-29-2024 10-Q
6 05-07-2024 03-30-2024 10-Q
7 02-28-2024 12-30-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-08-2023 07-01-2023 10-Q
10 05-10-2023 04-01-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-09-2022 10-01-2022 10-Q
13 08-10-2022 07-02-2022 10-Q
14 05-03-2022 04-02-2022 10-Q
15 02-15-2022 01-01-2022 10-K
16 10-26-2021 10-02-2021 10-Q
17 07-27-2021 07-03-2021 10-Q
18 04-27-2021 04-03-2021 10-Q
19 02-23-2021 01-02-2021 10-K
20 10-27-2020 09-26-2020 10-Q
21 07-28-2020 06-27-2020 10-Q
22 04-28-2020 03-28-2020 10-Q
23 02-19-2020 12-28-2019 10-K
24 10-30-2019 09-28-2019 10-Q
25 07-31-2019 06-29-2019 10-Q
26 05-06-2019 03-30-2019 10-Q
27 02-26-2019 12-29-2018 10-K
28 10-31-2018 09-29-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-07-2018 03-31-2018 10-Q
31 02-28-2018 12-30-2017 10-K
32 10-31-2017 09-30-2017 10-Q
33 08-02-2017 07-01-2017 10-Q
34 05-04-2017 04-01-2017 10-Q
35 02-15-2017 12-31-2016 10-K
36 11-02-2016 10-01-2016 10-Q
37 08-03-2016 07-02-2016 10-Q
38 05-04-2016 04-02-2016 10-Q
39 02-24-2016 01-02-2016 10-K
40 11-06-2015 10-03-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 masimo-highlights-real-world-trial-data-for-masimo-set

The INSPIRE Trial Prospectively Assesses Pulse Oximeter Accuracy Using a Unique Real-world Study Design and in the Feasibility ...

 heres-how-much-100-invested-in-masimo-10-years-ago-would-be-worth-today

Masimo (NASDAQ: MASI) has outperformed the market over the past 10 years by 1.12% on an annualized basis producing an average a...

 btig-reiterates-buy-on-masimo-maintains-198-price-target

BTIG analyst Marie Thibault reiterates Masimo (NASDAQ:MASI) with a Buy and maintains $198 price target.

 consumer-tech-news-august-18august-22-powell-turns-dovish-as-walmart-target-earnings-steer-sentiment-while-ai-hangover-hits-palantir

Powell's dovish Jackson Hole tone, mixed WMT/TGT/TJX earnings, and an AI hangover led by PLTR's slide gave way to a lat...

 apple-restores-blood-oxygen-tracking-to-watch-after-customs-ruling--masimo-strikes-back-with-lawsuit-over-patent-rights

Apple reintroduced blood-oxygen tracking on its watches after a Customs ruling, but Masimo has sued to block the feature again.

 masimo-announces-fda-510k-clearance-of-expanded-indications-for-delta-hemoglobin-parameters-provided-with-o3-regional-oximetry

Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3's Delta Hemoglobin Parameters ...

 apple-to-reintroduce-blood-oxygen-feature-on-select-watches-following-customs-ruling

Apple to roll out redesigned Blood Oxygen feature for select U.S. Apple Watch models via software update, following a favorable...

 piper-sandler-maintains-overweight-on-masimo-raises-price-target-to-210

Piper Sandler analyst Jason Bednar maintains Masimo (NASDAQ:MASI) with a Overweight and raises the price target from $200 to...

 masimo-raises-fy2025-adj-eps-guidance-from-530-560-to-545-570-vs-498-est-sees-sales-1505b-1535b-vs-1519b-est

Masimo (NASDAQ:MASI) raises FY2025 Adj EPS guidance from $5.30-$5.60 to $5.45-$5.70 vs $4.98 analyst estimate. sees sales of $1...

 masimo-q2-adj-eps-133-beats-122-estimate-sales-370300m-beat-368622m-estimate

Masimo (NASDAQ:MASI) reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.22 by 8.75 ...

Core News & Articles

https://x.com/SarahKarlin/status/1937539272392733011 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION